Article
Population-specific effects of the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1) on HPA-axis activation.
Pharmacogenetics and genomics - 1 Dec 2007
Hernandez-Avila Carlos A, Covault Jonathan, Wand Gary, Zhang Huiping, Gelernter Joel, Kranzler Henry R
Abstract excerpt
BACKGROUND: Studies in European Americans (EAs) have shown that the hypothalamic-pituitary-adrenal (HPA)-axis activation by the opioid blockade is moderated by the single nucleotide polymorphism (SNP) A118G (Asn40Asp) at the mu-opioid receptor locus (OPRM1). We examined the effect of this, and of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
